Gyre Therapeutics, Inc.
GYRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001124105
No open-market purchases or sales by Gyre Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Gyre Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 89 | 69 | −20 |
| Shares | 22.4M | 20.2M | −2.18M (−9.7%) |
| Value | $113.0M | $87.7M | −$25.3M (−22.4%) |
New holders (10)
Institutions that held Gyre Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 448,197 | $1.94M | 0.00% |
| RBF Capital, LLC | 158,191 | $685.0K | 0.04% |
| Ergoteles LLC | 108,500 | $470.0K | 0.01% |
| HRT Financial LP | 89,800 | $388.0K | 0.00% |
| Tibra Equities Europe Ltd | 79,200 | $343.0K | 0.11% |
| Trexquant Investment LP | 32,220 | $140.0K | 0.01% |
| Advisory Services Network, LLC | 19,700 | $85.0K | 0.00% |
| XTX Topco Ltd | 15,265 | $66.0K | 0.02% |
| Group One Trading, L.P. | 6,508 | $28.0K | 0.00% |
| Quadrant Capital Group LLC | 336 | $1.00K | 0.00% |
Sold out (30)
Institutions that held Gyre Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.